9:32 AM
Jan 11, 2019
 |  BC Week In Review  |  Financial News  |  Completed Offerings

InnoCare raises $160M to advance Btk inhibitor

InnoCare Pharma Ltd. (Beijing, China) said on Jan. 4 that it raised $160 million in a venture round led by Loyal Valley Capital with participation from 3H...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >